Pharmacological inhibition of Chk1/Chk2 induces cellular radiosensitivity, impairing DNA repair and triggering mitotic catastrophe, in the human colon cancer cell line HT-29 [30]. Here, CHEK2 is linked to malignant colon neoplasm.